CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Inhaled budesonide and formoterolWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1212 Inhaled placebo Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D000860 Hypoxia NIH 0.23
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (2)


Name (Synonyms) Correlation
HP:0012418 Hypoxemia HPO 0.23
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials


1 ARrest RESpiraTory Failure From PNEUMONIA (ARREST PNEUMONIA)

This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

NCT04193878 Pneumonia Hypoxemia Acute Respiratory Failure Drug: Inhaled budesonide and formoterol Drug: Inhaled placebo
MeSH:Pneumonia Respiratory Insufficiency Hypoxia
HPO:Hypoxemia Pneumonia

Primary Outcomes

Description: High flow nasal cannula (HFNC) and/or Noninvasive ventilation (NIV) use for greater than 36 hours OR Invasive mechanical ventilation for greater than 36 hours OR Death in a patient placed on respiratory support (HFNC, NIV, ventilator) who dies before 36 hours

Measure: Acute respiratory failure (ARF)

Time: within 7 days of randomization

Secondary Outcomes

Measure: Hospital length of stay

Time: within 60 days of randomization

Measure: Duration of need for supplemental oxygen

Time: within 60 days of randomization

Measure: Proportion of patients intubated for respiratory failure

Time: Within 7 days of randomization


Related HPO nodes (Using clinical trials)